CGC Publications
CGC Annual Meeting Abstracts
2023 | 2022 | 2021 | 2020 | 2019
CGC Publications
*Note: To access full length articles in the Cancer Genetics journal, you must be logged into your CGC account. In many cases the full length article may also be accessible to you via ScienceDirect.2022
Evidence-based review of genomic aberrations in diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS): Report from the cancer genomics consortium lymphoma working group
Ashwini K.Yenamandra, Rebecca B. Smith, T. Niroshi Senaratne, Sung-Hae L. Kang, James M. Fink, Gregory Corboy, Casey A. Hodge, Xinyan Lu, Susan Mathew, Susan Crocker, Min Fang, on behalf of the Cancer Genomics Consortium Lymphoma Working Group.
Cancer Genet. 2022; 268–269:1-21.
Access Full Article (Members)
Pubmed | ScienceDirect
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
Peter Horak, Malachi Griffith, Arpad M. Danos, Beth A.Pitel, Subha Madhavan, Xuelu Liu, Cynthia Chow, Heather Williams, Leigh Carmody, Lisa Barrow-Laing, Damian Rieke, Simon Kreutzfeldt, Albrecht Stenzinger, David Tamborero, Manuela Benary, Padma Sheila Rajagopal, Cristiane M. Ida, Harry Lesmana, Laveniya Satgunaseelan, Jason D. Merker, Michael Y. Tolstorukov, Paulo Vidal Campregher, Jeremy L. Warner, Shruti Rao, Maya Natesan, Haolin Shen, Jeffrey Venstrom, Somak Roy, Kayoko Tao, Rashmi Kanagal-Shamanna, Xinjie Xu, Deborah I. Ritter, Kym Pagel, Kilannin Krysiak, Adrian Dubuc, Yassmine M. Akkari, Xuan Shirley Li, Jennifer Lee, Ian King, Gordana Raca, Alex H. Wagner, Marylin M. Li, Sharon E. Plon, Shashikant Kulkarni, Obi L. Griffith, Debyani Chakravarty, Dmitriy Sonkin.
Genet Med. 2022; 24(5):986-998.
Pubmed | ScienceDirect | View Standard
2020
Evidence-Based Review of Genomic Aberrations in B-Lymphoblastic Leukemia/Lymphoma: Report from the Cancer Genomics Consortium Working Group for Lymphoblastic Leukemia
Yassmine Akkari, Helene Bruyere, R. Tanner Hagelstrom, Rashmi Kanagal-Shamanna, Jie Liu, Minjie Luo, Fady M. Mikhail, Beth A. Pitel, Gordana Raca, Mary Shago, Lina Shao, Lisa R. Smith, Teresa A. Smolarek, Ashwini Yenamandra, Linda B. Baughn, on behalf of the Cancer Genomics Consortium B-ALL Working Group.
Cancer Genet. 2020; 243:52-72.
Access Full Article (Members)
Pubmed | ScienceDirect
Current Concepts in Breast Cancer Genomics: An Evidence-Based Review by the CGC Breast Cancer Working Group
Katherine B. Geiersbach, Hui Chen, Rajyasree Emmadi, Gloria T. Haskell, Xinyan Lu, Yajuan J. Liu, Karen Swisshelm, on behalf of the Cancer Genomic Consortium Breast Cancer Working Group.
Cancer Genet. 2020 Jun;244:11-20.
Access Full Article (Members)
Pubmed | ScienceDirect
Assessing Genome-wide Copy Number Aberrations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup
Yajuan J. Liu, Jane Houldsworth, Rajyasree Emmadi, Lisa Dyer, Daynna J. Wolff, on behalf of the Cancer Genomics Consortium Renal Neoplasia Working Group.
Cancer Genet. 2020 Jun;244:240-254
Access Full Article (Members)
Pubmed | ScienceDirect
Copy Number Assessment in the Genomic Analysis of CNS Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium (CGC) Working Group on Primary CNS Tumors
Stewart G. Neill, Jennifer Hauenstein, Marilyn M. Li, Yajuan J Liu, Minjie Luo, Debra F. Saxe, Azra H. Ligon, on behalf of the Cancer Genomics Consortium CNS Tumor Working Group.
Cancer Genet. 2020 May; 243:19-47.
Access Full Article (Members)
Pubmed | ScienceDirect
2019
Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC).
Fady M. Mikhail, Jaclyn A. Biegel, Linda D. Cooley, Adrian M. Dubuc, Betsy Hirsch, Vanessa L. Horner, Scott Newman, Lina Shao, Daynna J. Wolff, Gordana Raca.
Genet Med. 2019 May 21(9):1903-1916.
Pubmed
2018
Assessing Copy Number Aberrations and Copy Neutral Loss of Heterozygosity Across the Genome as Best Practice: An Evidence Based Review of Clinical Utility from the Cancer Genomics Consortium (CGC) Working Group for Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative and Myeloproliferative Neoplasms
Rashmi Kanagal-Shamanna, Jennelle C.Hodge, Tracy Tucker, Shashi Shetty, Ashwini Yenamandra, Amanda Dixon-McIver, Christine Bryke, Emma Huxley, Patrick A.Lennon, Gordana Raca, Xinjie Xu, Sally Jeffries, Fabiola Quintero-Rivera, Patricia T. Greipp, Marilyn L.Slovak, Anwar Iqbal, Min Fang, on behalf of the Cancer Genomics Consortium MDS/MPN Working Group.
Cancer Genet. 2018 Dec; 228-229: 197-217
Access Full Article (Members)
Pubmed | ScienceDirect
Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group
Xinjie Xu, Christine Bryke, Madina Sukhanova, Emma Huxley, D P Dash, AmandaDixon-Mciver, Min Fang, Patricia Griepp, Jennelle C. Hodge, M. Anwar Iqbal,Sally Jeffries, Rashmi Kanagal Shamanna, Fabiola Quintero-Rivera, Shashi Shetty, Marilyn Slovak, Ashwini Yenamandra, Patrick A. Lennon, and Gordana Raca, on behalf of the Cancer Genomic Consortium Myeloid Neoplasm Working Group.
Cancer Genet. 2018 Dec;228-229: 218-235
Access Full Article (Members)
Pubmed | ScienceDirect
Assessing Copy Number Aberrations and Copy-neutral Loss-of-Heterozygosity Across the Genome as Best Practice: An Evidence-Based Review from the Cancer Genomics Consortium (CGC) Working Group for Chronic Lymphocytic Leukemia
Kathy Chun, Gail D. Wenger, Alka Chaubey, D.P. Dash, Rashmi Kanagal-Shamanna, Sibel Kantarci, Ravindra Kolhe, Daniel L. Van Dyke, Lu Wang, and Patricia M. Miron, on behalf of the Cancer Genomic Consortium CLL Working Group.
Cancer Genet. 2018 Dec; 228-229:236-250
Access Full Article (Members)
Pubmed | ScienceDirect
Assessing Genome-wide Copy Number Aberrations and Copy-Neutral Loss-of-Heterozygosity as Best Practice: An Evidence-Based Review from the Cancer Genomics Consortium Working Group for Plasma Cell Disorders
Trevor J. Pugh, James M. Fink, Xinyan Lu, Susan Mathew, Joyce Murata-Collins, Pascale Willem, Min Fang, on behalf of the Cancer Genomics Consortium Plasma Cell Disorders Working Group.
Cancer Genet. 2018 Dec; 228-229:184-196
Access Full Article (Members)
Pubmed | ScienceDirect
2015
A multicenter, cross-platform clinical validation study of cancer cytogenomic arrays
Marilyn M. Li, Federico A. Monzon, Jacyln A. Biegel, Vaidehi Jobanputra, Jennifer J. Laffin, Brynn Levy, Annette Leon, Patrician Miron, MIchael R. Rossi, Gokce Toruner, Karla Alvarez, Gregory Doho, Margaret J. Dougherty, Xiaofeng Hu, Shera Kash, Deanna Streck, Iya Znoyko, Jill M. Hagenkord, Daynna J. Wolff.
Cancer Genet. 2015 Nov; 208(11):525-536.
Access Full Article (Members)
Pubmed
